[Optimization of long-term care of neurological patients through internet- and mobile-based interventions with and without persuasive elements including gamification]. / Optimierung der Langzeitbetreuung von neurologischen Patienten durch internet- und mobile-basierte Interventionen ohne und mit persuasiven Elementen einschließlich der Gamification.

In a pilot study of 60 neurological long-term patients (degenerative cerebral microangiopathy with reduced sensorimotor stability), an initial assessment of the practicability of a specially developed concept was carried out focusing on the communication aspect of long-term medical treatment. Patient preferences, methods for increasing the patient's own activity and other factors determining adherence were analysed and optimised. In addition to communication and factual arguments, an affective-emotional, multi-layered message transmission is required, which adapts comprehensively and in real time to the recipient. Persuasion is the targeted addressing of behavioural patterns. Gamification transfers playful elements into a game-free context. Technology-based approaches offer an opportunity to optimize aspects of health, quality of life and positive disease management, e. g. through the use of internet- and mobile-based interventions (IMIs). Based on this information-theoretical and health-communicative background, a pilot study was conducted with 60 neurological long-term patients with symptomatic cerebral microangiopathy patients hospitalised for an existing sensorimotor incompetence. During the one-week inpatient stay, patients received an introduction to a standardized sensorimotor training therapy, which they then continued for six weeks after being discharged as a four-arm intervention study on an outpatient basis on the clinic campus or at home, each without and with gamification. Patients were examined at the beginning and end of the training phase with motor-functional procedures and test psychology. Thereafter, they were subjected to a standardised guideline interview. The most important results were as follows:- The training therapy was effective and was accepted by the patients. They attached particular importance to: high user-friendliness, high precision in reflecting their level of control of even subtle training elements, and personal progress evaluation in real time.- The domestic training results were better than those of the ambulance campus.- A comparison of the individual groups showed almost consistently better results under gamification, both at home and on an outpatient basis.

Lung disease caused by ABCA3 mutations.

BACKGROUND: Knowledge about the clinical spectrum of lung disease caused by variations in the ATP binding cassette subfamily A member 3 (ABCA3) gene is limited. Here we describe genotype-phenotype correlations in a European cohort. METHODS: We retrospectively analysed baseline and outcome characteristics of 40 patients with two disease-causing ABCA3 mutations collected between 2001 and 2015. RESULTS: Of 22 homozygous (15 male) and 18 compound heterozygous patients (3 male), 37 presented with neonatal respiratory distress syndrome as term babies. At follow-up, two major phenotypes are documented: patients with (1) early lethal mutations subdivided into (1a) dying within the first 6 months or (1b) before the age of 5 years, and (2) patients with prolonged survival into childhood, adolescence or adulthood. Patients with null/null mutations predicting complete ABCA3 deficiency died within the 1st weeks to months of life, while those with null/other or other/other mutations had a more variable presentation and outcome. Treatment with exogenous surfactant, systemic steroids, hydroxychloroquine and whole lung lavages had apparent but many times transient effects in individual subjects. CONCLUSIONS: Overall long-term (>5 years) survival of subjects with two disease-causing ABCA3 mutations was <20%. Response to therapies needs to be ascertained in randomised controlled trials.

Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3.

The ABCA3 gene encodes a lipid transporter in type II pneumocytes critical for survival and normal respiratory function. The frequent ABCA3 variant R288K increases the risk for neonatal respiratory distress syndrome among term and late preterm neonates, but its role in children's interstitial lung disease has not been studied in detail. In a retrospective cohort study of 228 children with interstitial lung disease related to the alveolar surfactant system, the frequency of R288K was assessed and the phenotype of patients carrying a single R288K variant further characterized by clinical course, lung histology, computed tomography and bronchoalveolar lavage phosphatidylcholine PC 32:0. Cell lines stably transfected with ABCA3-R288K were analyzed for intracellular transcription, processing and targeting of the protein. ABCA3 function was assessed by detoxification assay of doxorubicin, and the induction and volume of lamellar bodies. We found nine children with interstitial lung disease carrying a heterozygous R288K variant, a frequency significantly higher than in the general Caucasian population. All identified patients had neonatal respiratory insufficiency, recovered and developed chronic interstitial lung disease with intermittent exacerbations during early childhood. In vitro analysis showed normal transcription, processing, and targeting of ABCA3-R288K, but impaired detoxification function and smaller lamellar bodies. We propose that the R288K variant can underlie interstitial lung disease in childhood due to reduced function of ABCA3, demonstrated by decelerated detoxification of doxorubicin, reduced PC 32:0 content and decreased lamellar body volume.

Surfactant proteins in pediatric interstitial lung disease.

BACKGROUND: Children's interstitial lung diseases (chILD) comprise a broad spectrum of diseases. Besides the genetically defined surfactant dysfunction disorders, most entities pathologically involve the alveolar surfactant region, possibly affecting the surfactant proteins SP-B and SP-C. Therefore, our objective was to determine the value of quantitation of SP-B and SP-C levels in bronchoalveolar lavage fluid (BALF) for the diagnosis of chILD. METHODS: Levels of SP-B and SP-C in BALF from 302 children with chILD and in controls were quantified using western blotting. In a subset, single-nucleotide polymorphisms (SNPs) in the SFTPC promoter were genotyped by direct sequencing. RESULTS: While a lack of dimeric SP-B was found only in the sole subject with hereditary SP-B deficiency, low or absent SP-C was observed not only in surfactant dysfunction disorders but also in patients with other diffuse parenchymal lung diseases pathogenetically related to the alveolar surfactant region. Genetic analysis of the SFTPC promoter showed association of a single SNP with SP-C level. CONCLUSION: SP-B levels may be used for screening for SP-B deficiency, while low SP-C levels may point out diseases caused by mutations in TTF1, SFTPC, ABCA3, and likely in other genes involved in surfactant metabolism that remain to be identified. We conclude that measurement of levels of SP-B and SP-C was useful for the differential diagnosis of chILD, and for the precise molecular diagnosis, sequencing of the genes is necessary.

Genome-wide significant association with seven novel multiple sclerosis risk loci.

OBJECTIVE: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors. METHODS: The lead SNPs of all 11 loci were genotyped in 10 796 MS cases and 10 793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis. RESULTS: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21 589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101 683) revealed novel genome-wide significant association with MS susceptibility (p<5×10(-8)) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03×10(-12)), CD28 (rs6435203, p=1.35×10(-9)), LPP (rs4686953, p=3.35×10(-8)), ETS1 (rs3809006, p=7.74×10(-9)), DLEU1 (rs806349, p=8.14×10(-12)), LPIN3 (rs6072343, p=7.16×10(-12)) and IFNGR2 (rs9808753, p=4.40×10(-10)). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus. CONCLUSIONS: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases.

Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

BACKGROUND: Hyperzincemia and hypercalprotectinemia (Hz/Hc) is a distinct autoinflammatory entity involving extremely high serum concentrations of the proinflammatory alarmin myeloid-related protein (MRP) 8/14 (S100A8/S100A9 and calprotectin). OBJECTIVE: We sought to characterize the genetic cause and clinical spectrum of Hz/Hc. METHODS: Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene sequencing was performed in 14 patients with Hz/Hc, and their clinical phenotype was compared with that of 11 patients with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome. PSTPIP1-pyrin interactions were analyzed by means of immunoprecipitation and Western blotting. A structural model of the PSTPIP1 dimer was generated. Cytokine profiles were analyzed by using the multiplex immunoassay, and MRP8/14 serum concentrations were analyzed by using an ELISA. RESULTS: Thirteen patients were heterozygous for a missense mutation in the PSTPIP1 gene, resulting in a p.E250K mutation, and 1 carried a mutation resulting in p.E257K. Both mutations substantially alter the electrostatic potential of the PSTPIP1 dimer model in a region critical for protein-protein interaction. Patients with Hz/Hc have extremely high MRP8/14 concentrations (2045 ± 1300 µg/mL) compared with those with PAPA syndrome (116 ± 74 µg/mL) and have a distinct clinical phenotype. A specific cytokine profile is associated with Hz/Hc. Hz/Hc mutations altered protein binding of PSTPIP1, increasing interaction with pyrin through phosphorylation of PSTPIP1. CONCLUSION: Mutations resulting in charge reversal in the y-domain of PSTPIP1 (E→K) and increased interaction with pyrin cause a distinct autoinflammatory disorder defined by clinical and biochemical features not found in patients with PAPA syndrome, indicating a unique genotype-phenotype correlation for mutations in the PSTPIP1 gene. This is the first inborn autoinflammatory syndrome in which inflammation is driven by uncontrolled release of members of the alarmin family.

Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients.

Patients with interstitial lung disease due to surfactant protein C (SFTPC) mutations are rare and not well characterised. We report on all subjects collected over a 15-year period in the kids-lung register with interstitial lung disease and a proven SFTPC mutation. We analysed clinical courses, interventions and outcomes, as well as histopathological and radiological interrelations. 17 patients (seven male) were followed over a median of 3 years (range 0.3-19). All patients were heterozygous carriers of autosomal dominant SFTPC mutations. Three mutations (p.L101P, p.E191 K and p.E191*) have not been described before in the context of surfactant protein C deficiency. Patients with alterations in the BRICHOS domain of the protein (amino acids 94-197) presented earlier. At follow-up, one patient was healthy (2 years), six patients were "sick-better" (2.8 years, range 0.8-19), seven patients were "sick-same" (6.5 years, 1.3-15.8) and three patients were "sick-worse" (0.3 years, 0.3-16.9). Radiological findings changed from ground-glass to increasing signs of fibrosis and cyst formation with increasing age. Empiric treatments had variable effects, also in patients with the same genotype. Prospective studies with randomised interventions are urgently needed and can best be performed in the framework of international registers.

Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations.

OBJECTIVES: To assess subclinical inflammation in heterozygous carriers of Mediterranean fever (MEFV) gene mutations, analysis of classical inflammation markers and S100A12 was performed. METHODS: Exons 2, 3, and 10 of the MEFV gene, C-reactive protein (CRP), serum amyloid A protein (SAA), procalcitonin (PCT), and S100A12 concentrations, erythrocyte sedimentation rate (ESR), and differential blood count were analysed in apparently healthy parents (n=26) of homozygous children with familial Mediterranean fever (FMF). Their general health condition was assessed by a standardised questionnaire. In order to collect data on the disease course, subjects were reevaluated after 5 years by means of telephone interview and/or questionnaire. RESULTS: Twenty-two individuals with one typical mutation in the MEFV gene were included. Mean values (mean±SEM) of classical inflammation markers were within the normal range (ESR of 11.7±1.9 mm/h, SAA 4.7±0.4 mg/l, CRP 0.26±0.04 mg/dl), while PCT was non-detectable in all cases (<0.1 µg/l). Eleven subjects showed elevated S100A12 levels [>140 ng/ml] with a mean concentration of 205±43 ng/ml. Thus, the mean value of S100A12 was 1.5-fold higher than the regular cut-off. CONCLUSIONS: 50% of the heterozygous MEFV mutation carriers exhibited elevated S100A12 levels, supporting previous observations that S100 molecules are very sensitive biomarkers of subclinical inflammation. Possibly, S100A12 could be a prognostic biomarker to detect individuals at risk of FMF manifestation who might benefit from colchicine therapy.

Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.

Recent large-scale association studies have identified over 100 MS risk loci. One of these MS risk variants is single-nucleotide polymorphism (SNP) rs17066096, located ~14 kb downstream of IL22RA2. IL22RA2 represents a compelling MS candidate gene due to the role of IL-22 in autoimmunity; however, rs17066096 does not map into any known functional element. We assessed whether rs17066096 or a nearby proxy SNP may exert pathogenic effects by affecting microRNA-to-mRNA binding and thus IL22RA2 expression using comprehensive in silico predictions, in vitro reporter assays, and genotyping experiments in 6,722 individuals. In silico screening identified two predicted microRNA binding sites in the 3'UTR of IL22RA2 (for hsa-miR-2278 and hsa-miR-411-5p) encompassing a SNP (rs28366) in moderate linkage disequilibrium with rs17066096 (r (2) = 0.4). The binding of both microRNAs to the IL22RA2 3'UTR was confirmed in vitro, but their binding affinities were not significantly affected by rs28366. Association analyses revealed significant association of rs17066096 and MS risk in our independent German dataset (odds ratio = 1.15, P = 3.48 × 10(-4)), but did not indicate rs28366 to be the cause of this signal. While our study provides independent validation of the association between rs17066096 and MS risk, this signal does not appear to be caused by sequence variants affecting microRNA function.

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.

Amyloidoses are characterized by organ deposition of misfolded proteins. This study evaluated immunohistochemistry as a diagnostic tool for the differentiation of amyloid subentities, which is warranted for accurate treatment. A total of 117 patients were systematically investigated by clinical examination, laboratory tests, genotyping, and immunohistochemistry on biopsy specimens. Immunohistochemistry enabled the classification in 94% of the cases. For subsequent analysis, the patient population was divided into 2 groups. The first group included all patients whose diagnosis could be verified by typical clinical signs or an inherited amyloidogenic mutation. In this group, immunohistochemical subtyping was successful in 49 of 51 cases and proved accurate in each of the 49 cases, corresponding to a sensitivity of 96% and a specificity of 100%. The second group included patients with systemic light chain amyloidosis without typical signs, senile transthyretin, or hereditary amyloidosis with a concomitant monoclonal gammopathy. Immunohistochemistry allowed to define the subentities in 61 of 66 (92%) of these cases. Immunohistochemistry performed by a highly specialized pathologist combined with clinical examination and genotyping leads to a high accuracy of amyloidosis classification and is the standard in our center. However, new techniques, such as mass spectroscopy-based proteomics, were recently developed to classify inconclusive cases.

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.

A recent genome-wide association study reported five loci for which there was strong, but sub-genome-wide significant evidence for association with multiple sclerosis risk. The aim of this study was to evaluate the role of these potential risk loci in a large and independent data set of ≈ 20,000 subjects. We tested five single nucleotide polymorphisms rs228614 (MANBA), rs630923 (CXCR5), rs2744148 (SOX8), rs180515 (RPS6KB1), and rs6062314 (ZBTB46) for association with multiple sclerosis risk in a total of 8499 cases with multiple sclerosis, 8765 unrelated control subjects and 958 trios of European descent. In addition, we assessed the overall evidence for association by combining these newly generated data with the results from the original genome-wide association study by meta-analysis. All five tested single nucleotide polymorphisms showed consistent and statistically significant evidence for association with multiple sclerosis in our validation data sets (rs228614: odds ratio = 0.91, P = 2.4 × 10(-6); rs630923: odds ratio = 0.89, P = 1.2 × 10(-4); rs2744148: odds ratio = 1.14, P = 1.8 × 10(-6); rs180515: odds ratio = 1.12, P = 5.2 × 10(-7); rs6062314: odds ratio = 0.90, P = 4.3 × 10(-3)). Combining our data with results from the previous genome-wide association study by meta-analysis, the evidence for association was strengthened further, surpassing the threshold for genome-wide significance (P < 5 × 10(-8)) in each case. Our study provides compelling evidence that these five loci are genuine multiple sclerosis susceptibility loci. These results may eventually lead to a better understanding of the underlying disease pathophysiology.

The effect of dye coverage on the performance of dye-sensitized solar cells with a cobalt-based electrolyte.

The effect of dye coverage of the mesoporous TiO2 electrode on the performance of dye-sensitized solar cells based on the cobalt tris(bipyridine) electrolyte and the D35 dye was studied in detail. The dye coverage was controlled by using a dye bath with different dye concentrations and containing an inert salt, LiClO4, which was found to promote equilibrium conditions in the dye adsorption process. The amount of adsorbed D35 dye on mesoporous TiO2 was reasonably fit using the Langmuir adsorption isotherm, with a binding constant of 55 000 M(-1). Upon increasing the dye coverage on the TiO2 electrode, the electron lifetime in the dye-sensitized solar cell increased remarkably, demonstrating the blocking behavior of the D35 dye at the TiO2-electrolyte interface. Consequently, the solar cell efficiency increased dramatically with the D35 dye coverage.

Electron and hole transfer dynamics of a triarylamine-based dye with peripheral hole acceptors on TiO2 in the absence and presence of solvent.

We investigated photoinduced primary charge transfer processes of the sensitizer E6 on TiO2 without solvent and in contact with the organic solvent acetonitrile and the ionic liquid 1-ethyl-3-methylimidazolium tetracyanoborate [C2mim](+)[B(CN)4](-) using transient absorption spectroscopy, spectroelectrochemistry, and DFT/TDDFT calculations. E6, which belongs to a family of triarylamine dyes for solar cell applications, features two peripheral triarylamine units which are connected via diether spacer groups to the core chromophore and are designed to act as hole traps. This function was confirmed by spectroelectrochemistry, where the E6˙(+) radical cation shows a considerably blue-shifted absorption compared to dyes without these two substituents. This indicates that one of the terminal triarylamine units must carry the positive charge. After photoexcitation of E6 at 520 nm (S0 → S1 band), electrons are injected into TiO2 predominantly within the cross-correlation time (<80 fs), with some subsequent delayed electron injection (τ ca. 250 fs). Importantly, a transient Stark shift (electrochromism) is observed (time constants ca. 0.8 and 12 ps) which is related to a changing electric field generated by the E6˙(+) radical cations and injected electrons. This field induces absorption shifts of the dye species on the surface. Interestingly, these dynamics are largely unaffected by solvent molecules. However, pronounced differences are observed on longer timescales. In contact with solvent, one observes an increase in the E6˙(+) absorption band above 600 nm with a time constant of 75 ps. This is assigned to hole transfer from the core chromophore to one of the peripheral triarylamine substituents. Electron-cation recombination occurs on much longer timescales and is multiexponential, with time constants of ca. 100 µs, 1 ms and 15 ms. Because of hole trapping, it is slower than for similar dyes lacking the peripheral triarylamines. Additional experiments were performed for E6 attached to the wide band gap semiconductor ZrO2. Here, electron injection occurs into surface trap states with subsequent recombination. Another fraction of non-injecting E6 molecules in S1 quickly decays to S0 (time constants 1 and 35 ps).

Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1ß.

Caspase-1 (Interleukin-1 Converting Enzyme, ICE) is a proinflammatory enzyme that plays pivotal roles in innate immunity and many inflammatory conditions such as periodic fever syndromes and gout. Inflammation is often mediated by enzymatic activation of interleukin (IL)-1ß and IL-18. We detected seven naturally occurring human CASP1 variants with different effects on protein structure, expression, and enzymatic activity. Most mutations destabilized the caspase-1 dimer interface as revealed by crystal structure analysis and homology modeling followed by molecular dynamics simulations. All variants demonstrated decreased or absent enzymatic and IL-1ß releasing activity in vitro, in a cell transfection model, and as low as 25% of normal ex vivo in a whole blood assay of samples taken from subjects with variant CASP1, a subset of whom suffered from unclassified autoinflammation. We conclude that decreased enzymatic activity of caspase-1 is compatible with normal life and does not prevent moderate and severe autoinflammation.

Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS).

An 11-year-old Turkish girl from a non-consanguineous family was suffering from joint pain, fever, hepatosplenomegaly, and respiratory insufficiency. Laboratory abnormalities were thrombocytopenia, elevated levels of serum transaminases, lactate dehydrogenase, and C-reactive protein (up to 193 mg / l), a hyperferritinaemia of 8030 ng/ml, and an increased sCD25. The tentative diagnosis of macrophage activation syndrome (MAS) was confirmed by the detection of a histiocytosis with haemophagocytosis in the bone marrow. Treatment with dexamethasone, cyclosporine A, and VP16 was successful. However, the diagnosis of MAS on the background of a systemic juvenile idiopathic arthritis was questionable because of recurrent, spontaneously remitting fever phases of 5 to 7 days duration without an obvious infectious aetiology. A positive family history of febrile episodes in three consecutive generations raised the suspicion of a dominantly inherited disease. Genetic studies revealed a likely pathogenetically relevant E56D/p.Glu85Asp mutation in exon 3 of the TNFRSF1A gene. Alterations of the MEFV gene, in contrast, were not found. To our knowledge, this is the first case of a macrophage activation syndrome as the initial manifestation of TRAPS. Similar case reports in patients with the far more common familial Mediterranean fever (FMF) have been published already.

Photoinduced ultrafast dynamics of the triphenylamine-based organic sensitizer D35 on TiO2, ZrO2 and in acetonitrile.

The relaxation dynamics of the dye D35 has been characterized by transient absorption spectroscopy in acetonitrile and on TiO(2) and ZrO(2) thin films. In acetonitrile, upon photoexcitation of the dye via the S(0) → S(1) transition, we observed ultrafast solvation dynamics with subpicosecond time constants. Subsequent decay of the S(1) excited state absorption (ESA) band with a 7.1 ps time constant is tentatively assigned to structural relaxation in the excited state, and a spectral decay with 203 ps time constant results from internal conversion (IC) back to S(0). On TiO(2), we observed fast (<90 fs) electron injection from the S(1) state of D35 into the TiO(2) conduction band, followed by a biphasic dynamics arising from changes in a transient Stark field at the interface, with time constants of 0.8 and 12 ps, resulting in a characteristic blue-shift of the S(0) → S(1) absorption band. Several processes can contribute to this spectral shift: (i) photoexcitation induces immediate formation of D35˙(+) radical cations, which initially form electron-cation complexes; (ii) dissociation of these complexes generates mobile electrons, and when they start diffusing in the mesoporous TiO(2), the local electrostatic field may change; (iii) this may trigger the reorientation of D35 molecules in the changing electric field. A slower spectral decay on a nanosecond timescale is interpreted as a reduction of the local Stark field, as mobile electrons move deeper into TiO(2) and are progressively screened. Multiexponential electron-cation recombination occurs on much longer timescales, with time constants of 30 µs, 170 µs and 1.4 ms. For D35 adsorbed on ZrO(2), there is no clear evidence for a transient Stark shift, which suggests that initially formed cation-electron (trap state) complexes do not dissociate to form mobile conduction band electrons. Multiexponential decay with time constants of 4, 35, and 550 ps is assigned to recombination between cations and trapped electrons, and also to a fraction of D35 molecules in S(1) which decay by IC to S(0). Differential steady-state absorption spectra of D35˙(+) in acetonitrile and dichloromethane provide access to the complete D(0) → D(1) band. The absorption spectra of D35 and D35˙(+) are well described by TDDFT calculations employing the MPW1K functional.

Regeneration and recombination kinetics in cobalt polypyridine based dye-sensitized solar cells, explained using Marcus theory.

Regeneration and recombination kinetics was investigated for dye-sensitized solar cells (DSCs) using a series of different cobalt polypyridine redox couples, with redox potentials ranging between 0.34 and 1.20 V vs. NHE. Marcus theory was applied to explain the rate of electron transfer. The regeneration kinetics for a number of different dyes (L0, D35, Y123, Z907) by most of the cobalt redox shuttles investigated occurred in the Marcus normal region. The calculated reorganization energies for the regeneration reaction ranged between 0.59 and 0.70 eV for the different organic and organometallic dyes investigated. Under the experimental conditions employed, the regeneration efficiency decreased when cobalt complexes with a driving force for regeneration of 0.4 eV and less were employed. The regeneration efficiency was found to depend on the structure of the dye and the concentration of the redox couples. [Co(bpy-pz)2](2+), which has a driving force for regeneration of 0.25 eV for the triphenylamine based organic dye, D35, was found to regenerate 84% of the dye molecules, when a high concentration of the cobalt complex was used. Recombination kinetics between electrons in TiO2 and cobalt(iii) species in the electrolyte was also studied using steady state dark current measurements. For cobalt complexes with highly positive redox potentials (>0.55 V vs. NHE) dark current was found to decrease, consistent with electron transfer reactions occurring in the Marcus inverted region. However, for the cobalt complexes with the most positive redox potentials an increase in dark current was found, which can be attributed to recombination mediated by surface states.

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

BACKGROUND: Single nucleotide polymorphisms (SNPs) rs429358 (ε4) and rs7412 (ε2), both invoking changes in the amino-acid sequence of the apolipoprotein E (APOE) gene, have previously been tested for association with multiple sclerosis (MS) risk. However, none of these studies was sufficiently powered to detect modest effect sizes at acceptable type-I error rates. As both SNPs are only imperfectly captured on commonly used microarray genotyping platforms, their evaluation in the context of genome-wide association studies has been hindered until recently. METHODS: We genotyped 12 740 subjects hitherto not studied for their APOE status, imputed raw genotype data from 8739 subjects from five independent genome-wide association studies datasets using the most recent high-resolution reference panels, and extracted genotype data for 8265 subjects from previous candidate gene assessments. RESULTS: Despite sufficient power to detect associations at genome-wide significance thresholds across a range of ORs, our analyses did not support a role of rs429358 or rs7412 on MS susceptibility. This included meta-analyses of the combined data across 13 913 MS cases and 15 831 controls (OR=0.95, p=0.259, and OR 1.07, p=0.0569, for rs429358 and rs7412, respectively). CONCLUSION: Given the large sample size of our analyses, it is unlikely that the two APOE missense SNPs studied here exert any relevant effects on MS susceptibility.